Lobato EB

Idioma: Ingles.
Referencias bibliográficas: 18
Paginas: 335-337
Archivo PDF: 65.71 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J Med 2006;354:483-95.

2. Moliterno DJ. Healing Achiles–sirolimus versus paclitaxel. N Engl J Med 2005;353:724-6.

3. Arjomand H, Turi Z, McCormick D, et al. Percutaneous coronary intervention: historical perspecitves, current status, and future direction. Am Heart J 2003;146:787-96.

4. Gawaz M, Neumann FJ, Ott I, et al. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy. Circulation 1996;94:279-85.

5. Caramori PRA, Lima VC, Seidelin PH, et al. Long-term endothelial dysfunction after coronary stenting. J Am Coll Cardiol 1999;34:1675-9.

6. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines On Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67.

7. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-40.

8. Biondi-Zoccai GG, Agostoni P, Abbate A, et al. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent controlled trials. Int J Cardiol 2005;100:119-23.

9. Sousa, JE, Costa, MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107:381-3.

10. Hill RA, Dundar Y, Bakhai A, et al. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 2004;25:902-19.

11. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes: lessons learned, lessons awaited. J Am Coll Cardiol 2006;47:2112-5.

12. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-47.

13. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcomes of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30.

14. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.

15. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans. J Am Coll Cardiol 2006;48:193-202.

16. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2006;296:epublished December 5, 2006. Available at: http://jama.ama-assn.org/cgi/reprint/297.2.joc60179v1. Accessed December 7, 2006.

17. Ong ATL, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005;45:2088-92.

18. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-9.